Pfizer’s one-time haemophilia B gene therapy Durveqtix granted EC approval
PMLiVE
by Emily Kimber
13h ago
More than 42,000 people globally are living with the rare bleeding disorder ..read more
Visit website
AstraZeneca signs exclusive licensing deal worth over $500m for Pinetree’s EGFR degrader
PMLiVE
by Emily Kimber
13h ago
The candidate has shown promising preclinical anti-tumour activity in drug- and TKI-resistant tumours ..read more
Visit website
AbbVie’s IL-23 inhibitor Skyrizi approved by EC to treat ulcerative colitis in adults
PMLiVE
by Emily Kimber
13h ago
The form of inflammatory bowel disease is estimated to affect five million people globally ..read more
Visit website
Ipsen gains ex-US rights to Day One’s brain cancer therapy in deal worth over $460m
PMLiVE
by Jen Brogan
13h ago
Paediatric low-grade gliomas are the most common type of brain tumour diagnosed in children ..read more
Visit website
Boehringer Ingelheim’s Metalyse recommended by NICE to treat stroke in adults
PMLiVE
by Jen Brogan
13h ago
Ischaemic stroke is responsible for around 85% of all stroke cases in the UK ..read more
Visit website
Unlocking access to CAR-T in Europe: progress and growing pains
PMLiVE
by Emily Kimber
2d ago
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value ..read more
Visit website
Novartis and Dren Bio enter bispecific antibody partnership worth up to $3bn
PMLiVE
by Emily Kimber
2d ago
The companies will aim to advance targeted myeloid engager programmes in oncology ..read more
Visit website
Pfizer shares positive late-stage results for haemophilia A gene therapy
PMLiVE
by Emily Kimber
2d ago
The rare bleeding disorder occurs in approximately 25 in every 100,000 male births globally ..read more
Visit website
Ionis’ investigational antisense therapy shows promise in Angelman syndrome
PMLiVE
by Emily Kimber
2d ago
ION582 is expected to enter late-stage development for the rare neurodevelopmental disorder in 2025 ..read more
Visit website
ICR study on cell competition mechanism could lead to new ways of treating cancer
PMLiVE
by Jen Brogan
2d ago
Female breast, lung, bowel and prostate cancers account for more than four in ten of all cancers worldwide ..read more
Visit website

Follow PMLiVE on FeedSpot

Continue with Google
Continue with Apple
OR